EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Redox processes in the treatment of advanced skin cancers

Celine Gergele, Julia Berner, Sander Bekeschus

Clinical & Experimental Metastasis · 27.04.2026 · 43 (3)

DOI: 10.1007/s10585-026-10404-2 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Clinical & Experimental Metastasis, online erschienen am 27.04.2026. Verfasst von Celine Gergele und 2 weiteren Autor:innen. Beteiligte Einrichtung: ZIK plasmatis, Leibniz Institute for Plasma Science and Technology (INP), Felix-Hausdorff-Str. 2, 17489, Greifswald, Germany. Hauptthemen laut MEDLINE: Skin Neoplasms, Reactive Oxygen Species, Antineoplastic Agents. Die Arbeit nennt 183 Literaturangaben. Gefördert von: European Fund for Regional Development.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Reactive oxygen and nitrogen species (ROS/RNS) are central regulators of cellular processes, governing signaling, metabolism, and stress responses. The source of reactive species, together with the capacity of antioxidant networks, determines whether redox signals support cell survival or provoke cytotoxicity. Dysregulation of redox homeostasis promotes genomic instability, metabolic reprogramming, immune evasion, and therapy resistance, thereby contributing to tumor initiation and progression. Tumors further adapt their metabolism and antioxidant defenses, which changes their sensitivity to oxidative stress. Consequently, redox biology emerges as a highly promising target for intervention. This review focuses on topical ROS‑based strategies for advanced skin cancer, offering an overview of fundamental redox principles and evaluating both conventional topical agents (e.g., 5‑fluorouracil and imiquimod) and direct ROS-producing modalities (e.g., photodynamic therapy and medical gas plasma). Topical ROS‑based interventions can impose defined oxidative stress on tumors, combining direct tumoricidal activity with immunogenic effects. While standard agents rely primarily on antiproliferative or immune‑stimulatory mechanisms, pro‑oxidant therapies intentionally generate ROS/RNS to induce tumor cell death and stimulate antitumor immunity. They therefore may synergize with drugs that impair antioxidant defenses or sensitize cells to ferroptosis. Advanced cutaneous malignancies are suited to topical redox interventions because their surface accessibility permits localized treatment that addresses unmet therapeutic needs. To translate these opportunities, harmonized delivery and dosimetry, validated biomarkers for tumor redox phenotypes, and prospective trials integrating pharmacodynamic and safety endpoints are required to guide patient selection and combination strategies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Skin NeoplasmsReactive Oxygen SpeciesAntineoplastic AgentsHumansOxidation-ReductionOxidative StressAntioxidantsReactive Nitrogen SpeciesAnimals

Stichwörter der Autor:innen

ROSReactive oxygen speciesSCCSquamous cell carcinoma

Substanzen

Reactive Oxygen SpeciesAntioxidantsReactive Nitrogen SpeciesAntineoplastic Agents

Autor:innen und Institutionen

  • ZIK plasmatis, Leibniz Institute for Plasma Science and Technology (INP), Felix-Hausdorff-Str. 2, 17489, Greifswald, Germany.
  • Department of Dermatology, Venerology, and Allergology, Rostock University Medical Center, Strempelstr. 13, 18057, Rostock, Germany.
  • ZIK plasmatis, Leibniz Institute for Plasma Science and Technology (INP), Felix-Hausdorff-Str. 2, 17489, Greifswald, Germany. sander.bekeschus@med.uni-rostock.de.
  • Department of Dermatology, Venerology, and Allergology, Rostock University Medical Center, Strempelstr. 13, 18057, Rostock, Germany. sander.bekeschus@med.uni-rostock.de.

Förderung

  • European Fund for Regional Development

Zitieren

APA

Gergele, C., Berner, J., & Bekeschus, S. (2026). Redox processes in the treatment of advanced skin cancers. Clinical & Experimental Metastasis, 43(3). https://doi.org/10.1007/s10585-026-10404-2

Vancouver

Gergele C, Berner J, Bekeschus S. Redox processes in the treatment of advanced skin cancers. Clinical & Experimental Metastasis. 2026;43(3). doi:10.1007/s10585-026-10404-2

BibTeX
@article{Gergele2026,
  author = {Gergele, Celine and Berner, Julia and Bekeschus, Sander},
  title = {Redox processes in the treatment of advanced skin cancers},
  journal = {Clinical & Experimental Metastasis},
  year = {2026},
  volume = {43},
  number = {3},
  doi = {10.1007/s10585-026-10404-2}
}
Kostenlos starten →